View of TREATMENT OUTCOMES OF PACLITAXEL–CARBOPLATIN–BEVACIZUMAB FOR RECURRENT OR METASTATIC EPITHELIAL OVARIAN CANCER AT NGHE AN ONCOLOGY HOSPITAL

Return to Issue Details TREATMENT OUTCOMES OF PACLITAXEL–CARBOPLATIN–BEVACIZUMAB FOR RECURRENT OR METASTATIC EPITHELIAL OVARIAN CANCER AT NGHE AN ONCOLOGY HOSPITAL Download Download PDF